Contents

Anti-Cancer Agents in Medicinal Chemistry, Volume 12 - Number 2

Editorial [ Hot Topic:Emerging Anticancer Effects of Antiresorptive Therapies (Guest Editor: Vera Hirsh)]

, 12(2): 94

Vera Hirsh


DOI: 10.2174/187152012799014940




The Chemistry of Bisphosphonates: From Antiscaling Agents to Clinical Therapeutics

, 12(2): 95 - 101

Leo Widler, Wolfgang Jahnke and Jonathan R. Green


DOI: 10.2174/187152012799014959




Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies

, 12(2): 102 - 113

Philippe Clezardin


DOI: 10.2174/187152012799014977




Anticancer Activity of Bisphosphonates in Breast Cancer

, 12(2): 114 - 122

Michael Gnant


DOI: 10.2174/187152012799014931




Bisphosphonate Anticancer Activity in Multiple Myeloma

, 12(2): 123 - 128

Evangelos Terpos


DOI: 10.2174/187152012799014986




Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers

, 12(2): 129 - 136

Fred Saad and Peter Mulders


DOI: 10.2174/187152012799014995




Bisphosphonates in Lung Cancer: Can They Provide Benefits Beyond Prevention of Skeletal Morbidity?

, 12(2): 137 - 143

Vera Hirsh


DOI: 10.2174/187152012799014922




Bisphosphonates and Breast Cancer Prevention

, 12(2): 144 - 150

Rowan T. Chlebowski and Nananda Col


DOI: 10.2174/187152012799014913




Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance

, 12(2): 151 - 162

Sylvia S. Gayle, Samuel L.M. Arnold, Ruth M. O'Regan and Rita Nahta


DOI: 10.2174/187152012799015002




Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?

, 12(2): 163 - 171

Tomoya Yokota


DOI: 10.2174/187152012799014968




Procathepsin D as a Tumor Marker, Anti-Cancer Drug or Screening Agent

, 12(2): 172 - 175

Vaclav Vetvicka and Martin Fusek


DOI: 10.2174/187152012799014904




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science